Captrust Financial Advisors Sangamo Therapeutics, Inc Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$3.28 - $6.21 $2,273 - $4,303	-693 Reduced 35.89%	1,238 $5,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $402 - $602	-77 Reduced 3.83%	1,931 $11,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $1,742 - $2,621	239 Added 13.51%	2,008 $15,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $31,842 - $39,575	-3,131 Reduced 63.9%	1,769 $21,000
Q1 2021 May 17, 2021	BUY	$10.88 - $17.05 $12,762 - $19,999	1,173 Added 31.47%	4,900 $61,000
Q4 2020 Feb 16, 2021	SELL	$9.23 - $18.18 $11,555 - $22,761	-1,252 Reduced 25.15%	3,727 $58,000
Q3 2020 Nov 17, 2020	BUY	$9.38 - $12.48 $1,200 - $1,597	128 Added 2.64%	4,979 $47,000
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $30,124 - $57,387	4,851 New	4,851 $46,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.